2026 Global: Glucose Monitoring Devices Market-Competitive Review (2032) report
Description
The 2026 Global: Glucose Monitoring Devices Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Abbott Laboratories, headquartered in Abbott Park, Illinois, United States, is a dominant force in the glucose monitoring devices market, spearheading SMBG and CGM adoption with FreeStyle Libre and related sensors. Dexcom, based in San Diego, California, United States, has established itself as a leading CGM innovator with high-accuracy systems such as the Dexcom G6 and G7, widely used by patients and clinicians. Roche Diagnostics, headquartered in Basel, Switzerland, offers comprehensive glucose monitoring solutions through the Accu-Chek line, spanning meters, test strips, and CGM integrations that complement its expansive diabetes care portfolio. Medtronic plc, headquartered in Dublin, Ireland, integrates glucose sensing with insulin delivery platforms, advancing closed-loop treatment approaches and remote monitoring capabilities through its Guardian sensors and MiniMed systems. These firms drive innovation through sensor technology, data analytics, and cross-border distribution networks, shaping patient access and clinical outcomes. Such competition reinforces CGM and SMBG adoption across diverse healthcare settings, globally.
Senseonics Holdings, headquartered in Germantown, Maryland, United States, develops the Eversense implanted continuous glucose monitoring system, emphasizing long-term, skin-adjacent sensing and optional transmitter upgrades for regulated care facilities and ambulatory patients. Ascensia Diabetes Care, based in Basel, Switzerland, markets Contour and Contour Next SMBG meters and related testing solutions, leveraging its split ownership to expand global reach in both developed and emerging markets. Arkray, Inc., headquartered in Kyoto, Japan, manufactures glucose meters and test strips under the ARKRAY and CareSens brands, maintaining a broad distribution network across Asia, Europe, and the Americas. i-SENS, Inc., headquartered in Seoul, South Korea, produces the iBG Star and other meter platforms, pursuing collaborations with device manufacturers and digital health ecosystems to integrate data flows with mobile and cloud-based care. These firms expand the ecosystem by enabling cross-border supply, patient engagement, and data-driven decision making that informs clinical guidelines and reimbursement strategies. Worldwide adoption.
Menarini Diagnostics, headquartered in Florence, Italy, is a major global provider of SMBG solutions within the Menarini Group, offering a broad portfolio that includes meter systems, test strips, and software for calibration and data management. Nova Biomedical, headquartered in Waltham, Massachusetts, United States, supplies a range of glucose monitoring devices, point-of-care testing analyzers, and digital health integration tools designed for hospital and clinical settings. These companies maintain manufacturing footprints across North America, Europe, Asia, and Latin America, ensuring supply chain resilience, local regulatory alignment, and tailored pricing models that reflect market maturity and reimbursement dynamics. Beyond devices, these firms increasingly invest in data platforms, wearable integration, and telemedicine partnerships to translate glucose data into actionable clinical insights and improved patient outcomes. As regulatory pathways evolve, these leaders contend with reimbursement challenges, privacy concerns, and the need for standardized data formats that enable seamless sharing across providers and devices. Continued growth.
Abbott Laboratories, headquartered in Abbott Park, Illinois, United States, is a dominant force in the glucose monitoring devices market, spearheading SMBG and CGM adoption with FreeStyle Libre and related sensors. Dexcom, based in San Diego, California, United States, has established itself as a leading CGM innovator with high-accuracy systems such as the Dexcom G6 and G7, widely used by patients and clinicians. Roche Diagnostics, headquartered in Basel, Switzerland, offers comprehensive glucose monitoring solutions through the Accu-Chek line, spanning meters, test strips, and CGM integrations that complement its expansive diabetes care portfolio. Medtronic plc, headquartered in Dublin, Ireland, integrates glucose sensing with insulin delivery platforms, advancing closed-loop treatment approaches and remote monitoring capabilities through its Guardian sensors and MiniMed systems. These firms drive innovation through sensor technology, data analytics, and cross-border distribution networks, shaping patient access and clinical outcomes. Such competition reinforces CGM and SMBG adoption across diverse healthcare settings, globally.
Senseonics Holdings, headquartered in Germantown, Maryland, United States, develops the Eversense implanted continuous glucose monitoring system, emphasizing long-term, skin-adjacent sensing and optional transmitter upgrades for regulated care facilities and ambulatory patients. Ascensia Diabetes Care, based in Basel, Switzerland, markets Contour and Contour Next SMBG meters and related testing solutions, leveraging its split ownership to expand global reach in both developed and emerging markets. Arkray, Inc., headquartered in Kyoto, Japan, manufactures glucose meters and test strips under the ARKRAY and CareSens brands, maintaining a broad distribution network across Asia, Europe, and the Americas. i-SENS, Inc., headquartered in Seoul, South Korea, produces the iBG Star and other meter platforms, pursuing collaborations with device manufacturers and digital health ecosystems to integrate data flows with mobile and cloud-based care. These firms expand the ecosystem by enabling cross-border supply, patient engagement, and data-driven decision making that informs clinical guidelines and reimbursement strategies. Worldwide adoption.
Menarini Diagnostics, headquartered in Florence, Italy, is a major global provider of SMBG solutions within the Menarini Group, offering a broad portfolio that includes meter systems, test strips, and software for calibration and data management. Nova Biomedical, headquartered in Waltham, Massachusetts, United States, supplies a range of glucose monitoring devices, point-of-care testing analyzers, and digital health integration tools designed for hospital and clinical settings. These companies maintain manufacturing footprints across North America, Europe, Asia, and Latin America, ensuring supply chain resilience, local regulatory alignment, and tailored pricing models that reflect market maturity and reimbursement dynamics. Beyond devices, these firms increasingly invest in data platforms, wearable integration, and telemedicine partnerships to translate glucose data into actionable clinical insights and improved patient outcomes. As regulatory pathways evolve, these leaders contend with reimbursement challenges, privacy concerns, and the need for standardized data formats that enable seamless sharing across providers and devices. Continued growth.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
